Theralase Technologies Inc (TLTFF)

[BIGKAHUNA57]

If investors are foolish enough to push PUMO Biotechnology (PBYI)to over $100 in 2017, TLT's breakthrough cancer/virus cure/therapy is easily worth $20 to start. It could be worth that just for the melanoma application by itself. I mention PBYI b/c they are in the cancer treatment/cure space for breast cancer and NSCLC. So a competitor of sorts to TLT.

Watching this pps trade back and forth to the same groups, with minimal daily volume is laughable. As if we're not aware that a group of someones isn't suppressing the share price.

Time is all it takes to continue the progress and multiple applications for TLD1433 and all the rest. Stay patient my friends.

It's not a matter of if, but when this squeezes the shorts. Karma is a b!tch when it happens.

Happy New Year. Good luck to all. Regards,BK.